Post-Lipitor Pfizer Will Have Two Business Models: Innovation And Value
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer CEO Ian Read provided Wall Street with more clarity on his vision for the company as it moves beyond Lipitor into a new era. Pfizer will have two primary businesses, he said, an innovative pharmaceutical engine and a value business.